1. Collins FS. The Human Genome Project and the future of medicine. Annals of the New York Academy of Science. 1999;882:42–55. [PubMed]
2. Essential Nursing Competencies and Curricula Guidelines for Genetics and Genomics. Silver Spring, MD: American Nurses Association; 2006. Consensus Panel on Genetic/Genomic Nursing Competencies.
3. United States Department of Health and Human Services; Administration HRaS, editor. The Registered Nurse Population: Findings from the 2004 National Sample Survey of Registered Nurses. Washington D.C: Government Printing Office; 2004.
5. Anderson G, Monsen RB, Prows CA, Tinley S, Jenkins J. Preparing the nursing profession for participation in a genetic paradigm in health care. Nursing Outlook. 2000;48(1):23. [PubMed]
7. Scanlon C, Fibison W. Managing Genetic Information: Implication for Nursing Practice. Washington DC: American Nurses Publishing; 1995.
8. NCHPEG. Core competencies in genetics essential for all health care professionals. [6/26/2002]. 2002. web site] http://www.nchpeg.org/core. 9. Jenkins J, Calzone K. Establishing the essential nursing competencies for genetics and genomics. Journal of Nursing Scholarship. 2007;39(1):10–16. [PubMed]
10. American Association of Colleges of Nursing. The Essentials of Baccalaureate Education for Professional Nursing Practice. Washington DC: American Association of Colleges of Nursing; 2008.
11. Feetham SL, Williams jK, editors. Genetics in Nursing. 1st. Geneva, Switzerland: International Council of Nurses; 2004.
12. Guttmacher AE, Collins FS. Genomic medicine--a primer. New England Journal of Medicine. 2002;347(19):1512–1520. [PubMed] 13. Lashley FR. Genetics in Nursing Education. Nursing Clinics of North America. 2000;35(3):795–805. [PubMed]
14. Thomson EJ. Ethical, legal, social, and policy issues in genetics. In: Lashley FR, editor. The genetics revolution: Implications for nursing. Washington DC: American Academy of Nursing; 1997. pp. 15–26.
15. ELSI. A review and analysis of the ethical, legal, and social implications research programs at the National Institutes of Health and Department of Energy: Final report of the ELSI Research Planning and Evaluation Group [Online] [2/10, 2000]. web site] http://www.doe.gov.
16. Parens E, Asch A, editors. Prenatal testing and disability rights. First. Washington DC: Georgetown University Press; 2000.
17. Hamilton RJ, Bowers BJ, Williams JK. Disclosing genetic test results to family members. Journal of Nursing Scholarship. 2005;37(1):18–24. [PubMed] 18. Hamilton RJ, Williams JK, Bowers BJ, Calzone K. Life trajectories, genetic testing, and risk reduction decisions in 18-39 year old women at risk for hereditary breast and ovarian cancer. Journal of Genetic Counseling. 2008 [PMC free article] [PubMed]
19. Rosenblatt A, Ranen NG, Nance MA, Paulsen JS. A physician's guide to the management of Huntington's Disease. 2nd. New York: Huntington's Disease Society of America; 1999.
20. Oster E, Dorsey ER, Bausch J, et al. American Journal of Medical Genetics. 146A. 2008. Fear of health insurance loss among individuals at risk for Huntington disease; pp. 2070–2077.
21. Quaid KA, Morris M. Reluctance to Undergo Predictive Testing: The Case of Huntington Disease. American Journal of Medical Genetics. 1993;45:41–45. [PubMed]
22. Hamilton RJ. Dissertation. Madison, WI: 2003. Experiencing predictive genetic testing in families with Huntington's disease and hereditary breast and ovarian cancer. Unpublished dissertation.
23. Williams JK, Schutte DL, Evers C, Holkup PA. Redefinition: Coping with normal results from predictive gene testing for neurodegenerative disorders. Research in Nursing & Health. 2000;23:260–269. [PubMed] 24. Hamilton RJ, Bowers BJ. The Theory of Genetic Vulnerability: A Roy model exemplar. Nursing Science Quarterly. 2007;20(3):254–265. [PubMed]
25. Scanlon C, Fibison, Forsman, Jones, Soeken Managing Genetic Information: Implications for Nursing Practice. Washington, DC: American Nurses Publishing; 1995.
26. American Nurses Association. Code for nurses with interpretive statements. Washington, D.C.: American Nurses Association; 1985.
27. Collins F. Shattuck lecture-medical and societal consequences of the human genome project. The New England Journal of Medicine. 1999;341(1):28–37. [PubMed] 28. Bertram L, Tanzi RE. The genetic epidemiology of neurodegenerative disease. Journal of Clinical Investigation. 2005;115(6):1149–1457. [PMC free article] [PubMed]
29. Quaid KA. Implications of genetic susceptibility testing with Apolipoprotien E. In: Post SG, Whitehouse PJ, editors. Genetic testing for Alzheimer disease: Ethical and clinical issues. Baltimore: John Hopkins University Press; 1998. pp. 118–139.
30. Dugan RB, Weisner GL, Juengst ET, O'Riordan MA, Matthews AL, Robin NH. Duty to warn at-risk relatives for genetic disease: Genetic counselors' clinical experience. American Journal of Medical Genetics Part C (Semin. Med. Genet.) 2003;119C:27–34. [PubMed] 31. Hallowell N, Foster C, Eeles R, Ardern-Jones A, Murday V, Watson M. Balancing autonomy and responsibility: The ethics of generating and disclosing genetic information. Journal of Medical Ethics. 2003;29(2):74–91. [PMC free article] [PubMed] 32. Hallowell N, Ardern-Jones A, Eeles R, et al. Communication about genetic testing in families of male BRCA1/2 carriers and non-carriers: Patterns, priorities and problems. Clinical Genetics. 2005;67:492–502. [PubMed] 33. Forrest K, Simpson SA, Wilson BJ, et al. To tell or not to tell: Barriers and facilitators in family communication about genetic risk. Clinical Genetics. 2003;64:317–326. [PubMed] 34. Wilson BJ, Forrest K, van Teijlingen ER, et al. Family communication about genetic risk: The little that is known. Community Genetics. 2004;7:15–24. [PubMed]
35. Roche PA. Caveat venditor: protecting privacy and ownership interests in DNA. In: Knoppers BM, editor. Human DNA: law & policy. pp. 33–41.
36. Annas GJ, Glantz LH, Roche PA. Drafting the Genetic Privacy Act: Science, Policy, and Practical Considerations. Journal of Law, Medicine & Ethics. 1995;23:360–366. [PubMed]
37. Williams S. “Who Owns Your Genes?” Event Illuminates Arguments For and Against DNA Patenting. Biotech Briefing. 2007;4:3–6.
38. Prows CA, Prows DR. Medication Selection by Genotype. AJN. 2004;104(5):60–70. [PubMed]
39. Lashley FR. Clinical Genetics in Nursing Practice. 3rd. New York: Springer Publishing Company; 2005.
40. Florez JC. The genetics of Type 2 Diabetes: A realistic appraisal CIRCA 2008. Journal of Clinical Endocrine Metabolism. 2008 Online ahead of print.
41. Hamilton A. Time's best inventions of 2008. Time. 2008 November 10;:68–69. Vol.
42. Hudson K, Javitt G, Burke W, Byers P. ASHG Statement on Direct-to-Consumer Genetic Testing in the United States. The American Journal of Human Genetics. 2007;81:635–637.
43. Prows CA. Clinical aspects of genomics: An update. OJIN: The Online Journal of Issues in Nursing. 2008;13(1)
44. Collins FS, Green ED, Guttmacher AE, Guyer MS. A vision for the future of genomics research. Nature. 2003;422:835–847. [PubMed]
46. International Council of Nurses. The ICN Code of Ethics for Nurses. Geneva, Switzerland: ICN; 2000.
48. Harmon A. THE DNA AGE; Fear of Insurance Trouble Leads Many to Shun or Hide DNA Tests. New York Times. 2008 February 24;